The study published in the American Journal of Obstetrics and Gynecology highlights the need for women and their providers to carefully examine medications taken during pregnancy.
The research provides important information to support the FDA’s REMS program which aims to prevent fetal exposure to mycophenolate.
The UF measure tracks 30-day hospital readmission rates for psychiatric patients following discharge.
The study published in JAMA Network Open found a substantial number of patients are being prescribed a loop diuretic for leg swelling induced by calcium channel blocker.
At the meeting, she was presented an "Outstanding Service Award," for her exceptional leadership in the field of drug safety.
University of Florida researchers determined an FDA-approved program deters pregnant women from starting a potentially harmful immunosuppressive drug. But for women taking the drug, the program was not effective at reducing conception.
UF Faculty and alumni took over several leadership roles in the society during the 35th International Conference on Pharmacoepidemiology in Philadelphia. Dr. Almut Winterstein, Professor and Chair of POP, was installed as the President of the International Society for Pharmacoepidemiology. She…
The inaugural Consortium for Medical Marijuana Clinical Outcomes board meeting was held on Aug. 19 in Gainesville.
UF researchers reviewed more than 13 million patients using carisoprodol, a powerful muscle relaxant.
As the lead institution, UF will receive $1.5 million in annual recurrent funding from the state of Florida to support the research mission of the Consortium for Medical Marijuana Clinical Outcomes Research.